EBV-directed viral-specific T-lymphocyte therapy for the treatment of EBV-driven lymphoma in two patients with primary immunodeficiency and DNA repair defects.

Authors

Jeremy D Rubinstein
Karen Burns
Michael Absalon
Carolyn Lutzko
Tom Leemhuis
Sharat Chandra
Patrick J. Hanley, George Washington University
Michael D. Keller, George Washington University
Stella M. Davies
Adam Nelson
Michael Grimley

Document Type

Journal Article

Publication Date

12-18-2019

Journal

Pediatric Blood & Cancer

Inclusive Pages

e28126

DOI

10.1002/pbc.28126

Comments

Epub ahead of print

APA Citation

Rubinstein, J., Burns, K., Absalon, M., Lutzko, C., Leemhuis, T., Chandra, S., Hanley, P. J., Keller, M. D., Davies, S. M., Nelson, A., & Grimley, M. (2019). EBV-directed viral-specific T-lymphocyte therapy for the treatment of EBV-driven lymphoma in two patients with primary immunodeficiency and DNA repair defects.. Pediatric Blood & Cancer, (). http://dx.doi.org/10.1002/pbc.28126

Peer Reviewed

1